Tim Robinson
Impact in
- Oncology top 5%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Oncology 14
- COVID-19 and healthcare impacts 6
- Cancer Risks and Factors 3
-
- Breast Cancer Treatment Studies 8
- Co-authors
- Richard Michael Martin (6 shared papers)Thomas Cronin (1 shared paper)Aanand N. Acharya (2 shared papers)Michael C. F. Smith (2 shared papers)Lucio Buffoni (1 shared paper)Fabrizio Tabbò (1 shared paper)Silvia Novello (1 shared paper)Alfredo Addeo (1 shared paper)
- Journals
- Clinical Oncology (3 papers)The Lancet Oncology (2 papers)British Journal of Cancer (2 papers)Scientific Reports (2 papers)European Journal of Cancer (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Tim Robinson
40 papers receiving 1.6k citations
Tim Robinson's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 512
- Infectious Diseases 344
- Genetics 257
- Cancer Research 110
- Speech and Hearing 36
Countries citing papers authored by Tim Robinson
This map shows the geographic impact of Tim Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Robinson more than expected).
Fields of papers citing papers by Tim Robinson
This network shows the impact of papers produced by Tim Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Robinson. The network helps show where Tim Robinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Hit paper breakdown → | 2020 | 450 |
| 2 | Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis Hit paper breakdown → | 2020 | 428 |
| 3 | 2013 | 111 | |
| 4 | 2022 | 76 | |
| 5 | 2011 | 58 | |
| 6 | 2018 | 47 | |
| 7 | 2022 | 45 | |
| 8 | 2017 | 44 | |
| 9 | 2014 | 36 | |
| 10 | 2022 | 34 | |
| 11 | 2020 | 32 | |
| 12 | 2022 | 27 | |
| 13 | 2024 | 27 | |
| 14 | 2016 | 24 | |
| 15 | 2020 | 23 | |
| 16 | 2023 | 23 | |
| 17 | 2014 | 22 | |
| 18 | 2022 | 22 | |
| 19 | 2023 | 21 | |
| 20 | 2006 | 17 |
About Tim Robinson
Tim Robinson is a scholar working on Oncology, Cancer Research, Infectious Diseases, Genetics and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 1.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Genetic Associations and Epidemiology (7 papers), COVID-19 and healthcare impacts (6 papers), Advanced Breast Cancer Therapies (3 papers), COVID-19 Clinical Research Studies (3 papers), Cancer Risks and Factors (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Circadian rhythm and melatonin (2 papers). The work is most often cited by research in Oncology (512 citations), Infectious Diseases (344 citations), Genetics (257 citations), Cancer Research (110 citations) and Speech and Hearing (36 citations). Tim Robinson has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Richard Michael Martin, Thomas Cronin, Aanand N. Acharya, Michael C. F. Smith, Lucio Buffoni, Fabrizio Tabbò, Silvia Novello, Alfredo Addeo, James Yarmolinsky and Jeremy P. Braybrooke. Their work appears in journals such as Clinical Oncology, The Lancet Oncology, British Journal of Cancer, Scientific Reports and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.